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Copper is an essential micronutrient that is necessary for healthy
immune function. This requirement is underscored by an increased susceptibility to bacterial infection in copper-deficient animals; however, a molecular understanding of its importance in
immune defense is unknown. In this study, we investigated the
effect of proinflammatory agents on copper homeostasis in
RAW264.7 macrophages. Interferon-␥ was found to increase
expression of the high affinity copper importer, CTR1, and stimulate copper uptake. This was accompanied by copper-stimulated trafficking of the ATP7A copper exporter from the Golgi
to vesicles that partially overlapped with phagosomal compartments. Silencing of ATP7A expression attenuated bacterial killing, suggesting a role for ATP7A-dependent copper transport
in the bactericidal activity of macrophages. Significantly, a
copper-sensitive mutant of Escherichia coli lacking the CopA
copper-transporting ATPase was hypersensitive to killing by
RAW264.7 macrophages, and this phenotype was dependent
on ATP7A expression. Collectively, these data suggest that
copper-transporting ATPases, CopA and ATP7A, in both bacteria and macrophage are unique determinants of bacteria survival and identify an unexpected role for copper at the hostpathogen interface.

Copper is an essential nutrient for aerobic organisms. Its
ability to exchange electrons as it cycles between cuprous
and cupric states has been harnessed by enzymes that catalyze a wide variety of biochemical processes (1). However,
this same redox activity also confers copper with toxic properties when it is present in the free ionic form. Free copper can
participate in Fenton-like chemistry to produce the highly toxic
hydroxyl radical from hydrogen peroxide and superoxide
(2– 4). It is therefore not surprising that organisms have evolved
tightly regulated mechanisms for copper transport and intracellular distribution.
Copper is among several micronutrients found to be important for both innate and adaptive immunity (5, 6). Copper defi-
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ciency decreases interleukin-2 secretion in T cells (7), and
recent studies have demonstrated a direct role for copper in the
secretion of interleukin 1-␣ and fibroblast growth factor-1 (8).
Various studies have shown that copper-deficient animals are
susceptible to several pathogens, including Candida albicans
(9, 10), Pasteurella hemolytica (11), Trypanosoma lewisi (12),
and Salmonella typhimurium (13). Other studies have shown
that copper supplementation is protective against Escherichia
coli-induced mastitis in dairy cattle (14). In vitro studies have
shown that copper deficiency impairs the bactericidal activity
of neutrophils and macrophages (15, 16). Moreover, a recent
study demonstrated that copper concentrations are markedly
increased within the phagosomal compartment of macrophages activated by interferon-␥ (IFN-␥)3 and Mycobacterium
avium (18). Although these studies provide indirect evidence of
a role for copper in immune defense, an understanding of the
underlying processes at a molecular level is lacking.
Here we report dramatic changes in copper homeostasis
triggered by proinflammatory agents in macrophages, a
phagocytic cell type of the innate immune system. These
changes include elevated expression of the CTR1 copper importer, increased copper uptake, and copper-stimulated trafficking of the ATP7A copper transporter from the Golgi to
cytoplasmic vesicles that overlap with the phagosomal compartment. Significantly, silencing of ATP7A impaired bactericidal activity, suggesting that copper transport via ATP7A was
required for bacterial killing. Consistent with this role, a copper-sensitive mutant of E. coli with a defect in copper export
was significantly more sensitive to macrophage-mediated killing
than wild type cells, and this sensitivity was dependent on ATP7A
expression. These findings suggest that copper-transporting
ATPases present within both macrophage and bacteria are novel
determinants of this host-pathogen interaction.

EXPERIMENTAL PROCEDURES
Cell Culture—RAW264.7 cells were obtained from the American Type Culture Collection and were maintained in Dulbecco’s
modified Eagle’s medium (Invitrogen) containing 10% fetal
bovine serum and 100 units/ml penicillin and streptomycin
(Invitrogen) in 5% CO2 at 37 °C. ATP7A-silenced RAW264.7
cells were generated by stable transfection of a pRS vector harboring a 29-nucleotide short hairpin RNA against ATP7A (Origene, Rockville, MD) and selected in 25 g/ml puromycin
3

The abbreviations used are: IFN-␥, interferon ␥; LPS, lipopolysaccharide;
RNAi, RNA interference; TTM, tetrathiomolybdate.
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(Invitrogen). Control cells were transfected with the same vector expressing short hairpin RNA against green fluorescent
protein (Origene). The Rab7-Q67L plasmid was transiently
transfected into RAW264.7 cells using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Copper Uptake Studies—64Cu uptake was assayed as described previously with minor modifications (19). RAW264.7
macrophage cells in triplicate 6-well trays were cultured
overnight in 1 ml of serum-free medium with or without the
indicated concentrations of IFN-␥ (BD Biosciences) or LPS
(Sigma). Cells were then incubated with serum-free medium
containing 1 M 64Cu for 5 min, washed extensively in ice-cold
phosphate-buffered saline, and scraped into phosphate-buffered saline. Radioactivity was measured using a ␥ counter, and
counts were determined per total protein concentration.
Bacterial Survival Assays—RAW264.7 cells alone or transfected with control RNAi or ATP7A RNAi plasmids were activated by overnight treatment in serum-free medium containing
25 ng/ml IFN-␥. Where indicated, either 20 M CuCl2 or 50 M
ebselen was also added to the cells. Cells were then detached by
scraping into ice-cold serum-free medium, washed twice, and
resuspended in triplicate in serum-free medium. Wild type
E. coli (strain W3110) or the copA deletion strain (DW3110) (20,
21) were grown to stationary phase and added to the RAW264.7
macrophages at a macrophage/bacteria ratio of 1:10 or 1:1. Bacterial phagocytosis was allowed to proceed for 30 min at 37 °C, and
the extracellular bacteria were removed by two washes with phosphate-buffered saline containing 12.5 g/ml gentamicin (Invitrogen). One set of samples (uptake group) was lysed in 0.1% Triton
X-100 solution and plated onto LB-agar plates for colony counting
to provide bacterial uptake values. The remaining set (kill group)
was incubated for 1 or 2 h (as indicated) at 37 °C in serum-free
medium to allow bacterial killing to occur, lysed, and then plated
onto LB-agar. Colony numbers were normalized against the total
protein content of each sample, and bacterial survival was determined by dividing the number of colonies in the killing group by
those in the uptake group.
In Vitro Bactericidal Assay—The in vitro survival assay was
performed as previously described (22). Briefly, exponential
phase cultures of E. coli were pelleted and resuspended in 1 ml
of assay buffer (0.1 M sodium phosphate, pH 7.4, 0.15 M NaCl,
and 0.5 mM ascorbic acid to act as a reducing agent) in the
presence or absence of 500 M H2O2, 10 M copper, or both, for
20 min at 37 °C. Serial dilutions of bacteria were plated, and
bacterial survival rates were expressed as a percentage of the
untreated group in assay buffer alone.
Immunological Techniques—Immunofluorescence microscopy and Western blot analysis were performed as described
previously (23).
Latex Bead Phagocytosis and Phagosome Purification—
RAW264.7 cells were activated by overnight treatment with 25
ng/ml IFN-␥ and exposed to a 1:200 dilution of 3-m latex
beads (Sigma) for 90 min at 37 °C to allow phagocytosis to proceed. Cells were then washed with phosphate-buffered saline to
remove extracellular beads and fixed in paraformaldehyde and
processed for immunofluorescence as above. In other experiments, bead-containing phagosomes were purified by sucrose
gradient centrifugation as described previously (24).
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FIGURE 1. Copper enhances bacterial killing by RAW264.7 macrophage
cells. A, RAW264.7 macrophages were treated with 25 ng/ml IFN-␥ in the
presence or absence of 20 M copper prior to exposure to E. coli for 30 min to
allow phagocytosis to occur. After removal of extracellular bacteria, bacterial
survival was measured following incubations for 1 or 2 h at 37 °C and
expressed as a percentage of initial internalized E. coli (mean ⫾ S.D.; n ⫽ 3;
p ⬍ 0.05, Student’s t test). B, in vitro bacterial survival was assessed following
exposure of E. coli to 0.5 mM H2O2, 10 M CuCl2 or H2O2 plus CuCl2. Bacterial
survival rates were calculated and expressed as percentage survival compared with the untreated group (mean ⫾ S.D.; n ⫽ 3; p ⬍ 0.05). Different letters
signify values of significant difference (Tukey’s post hoc analysis). C, bacterial
survival was assayed after 2 h in IFN-␥-treated RAW264.7 macrophages in the
presence or absence of 20 M copper and a 50 M concentration of the antioxidant ebselen (mean ⫾ S.D.; n ⫽ 3; p ⬍ 0.05, one- and two-way analysis of
variance). Different letters signify values of significant difference (Tukey’s post
hoc analysis).

Ceruloplasmin Activity—Conditioned medium was concentrated using Amicon Ultra-4 filter tubes (Millipore), and ceruloplasmin activity was assayed as described previously (25).

RESULTS
Copper Enhances the Bactericidal Activity of Macrophages—
We began this study by testing whether copper supplementation to the growth medium of the murine macrophage cell line,
VOLUME 284 • NUMBER 49 • DECEMBER 4, 2009
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FIGURE 3. Proinflammatory agents stimulate ATP7A expression in
RAW264.7 cells. Western blot analysis of ATP7A protein levels in total cell
lysates of RAW264.7 macrophage cells exposed for 24 h to a range of IFN-␥
(A) and LPS concentrations (B). Relative band intensities against tubulin
are shown in parentheses.

FIGURE 2. Proinflammatory agents stimulate copper uptake and CTR1
expression in RAW264.7 cells. A, copper uptake activity. RAW264.7 cells
were pretreated with serum-free medium with or without IFN-␥ or LPS at the
indicated concentrations for 24 h, and copper uptake in the presence of 1 M
64
Cu was measured over 5 min and expressed per total protein concentration
(mean ⫾ S.D.; n ⫽ 3; *, p ⬍ 0.05, Student’s t test). B, Western blot analysis of
CTR1 protein levels in total cell lysates of RAW264.7 macrophage cells
exposed for 24 h to a range of IFN-␥ and LPS concentrations. Relative band
intensities against tubulin are shown in parentheses.

RAW264.7, might alter its bactericidal activity. Cells were stimulated overnight with the proinflammatory cytokine, IFN-␥, in
the presence or absence of 20 M copper, and their ability to kill
E. coli was determined the following day. In the RAW264.7
macrophages pretreated with copper, bacterial survival was significantly reduced relative to untreated cells following either a
1- or 2-h incubation (Fig. 1A). There was no effect of copper on
the uptake of bacteria by RAW264.7 cells (data not shown).
These findings suggest that copper can potentiate the bactericidal activity of RAW264.7 cells. Previous in vitro studies have
demonstrated that bacteria are highly sensitive to low concentrations of Cu⫹ in the presence of hydrogen peroxide (H2O2)
(22), and we confirmed these findings in our study (Fig. 1B).
These data underscored the possibility that the enhanced bactericidal activity conferred by the copper treatment of macrophages may be dependent on reactive oxygen species. This
hypothesis was supported by the finding that pretreating the
RAW264.7 macrophage cells with ebselen, a cell-permeable
glutathione peroxidase mimetic, prevented the copper-mediated increase in bactericidal activity (Fig. 1C). Ebselen treatments did not alter the rate of phagocytosis of E. coli compared
with control RAW264.7 cells (data not shown). Taken together,
DECEMBER 4, 2009 • VOLUME 284 • NUMBER 49

FIGURE 4. Lipopolysaccharide and IFN-␥ induce trafficking of ATP7A in
RAW264.7 cells. Shown is immunofluorescence analysis of ATP7A protein in
RAW264.7 cells grown for 24 h in the presence of 100 ng/ml LPS, 25 ng/ml
IFN-␥, or 20 M CuCl2. Cells were fixed, permeabilized, and probed with antibodies against ATP7A and anti-rabbit antibodies conjugated to Alexa-488
(green) or antibodies against the Golgi marker GM130 and anti-mouse antibodies conjugated to Alexa-594 (red). Nuclei were labeled with 4⬘,6-diamidino-2-phenylindole (blue).
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FIGURE 6. Time course analysis of IFN-␥-stimulated ATP7A trafficking
and expression. Shown are immunofluorescence analysis (A) and Western
blot analysis (B) of ATP7A protein in RAW264.7 cells exposed to 25 ng/ml
IFN-␥ for the indicated times. Relative band intensities against tubulin are
shown in parentheses.

FIGURE 5. The trafficking of ATP7A in response to IFN-␥ is copper-dependent. A, IFN-␥-induced trafficking of ATP7A is inhibited by the copper
chelator TTM. RAW264.7 cells were cultured for 24 h in the presence of IFN-␥
with or without 10 nM TTM. ATP7A protein was detected by immunofluorescence microscopy after cells were fixed, permeabilized, and probed with antibodies against ATP7A and anti-rabbit antibodies conjugated to Alexa-488
(green). B, tetrathiomolybdate does not inhibit the increase in ATP7A protein
expression during inflammation. RAW264.7 were treated for 24 h with serumfree medium alone or the same medium containing 100 ng/ml LPS or 25
ng/ml IFN-␥ in the presence or absence of 10 nM TTM. ATP7A protein was
detected in total cell lysates by Western blot analysis. Relative band intensities against tubulin are shown in parentheses.

these findings suggest that copper can promote the bactericidal
activity of RAW264.7 macrophages in a reactive oxygen speciesdependent manner.
Inflammatory Mediators Induce the Expression of CTR1 and
ATP7A Copper Transporters—Since copper was found to potentiate the bacteridical activity of RAW264.7 cells, we investigated whether copper homeostasis might be altered
in these cells following stimulation with proinflammatory
agents. Treatment of RAW264.7 macrophages with the proinflammatory agents, IFN-␥ or LPS, stimulated copper uptake
activity in a dose-dependent manner (Fig. 2A). Immunoblot
analysis indicated that these effects of IFN-␥ and LPS were
associated with a dose-dependent increase in the expression of
the copper importer, CTR1 (Fig. 2C). Taken together, these
findings suggest that the inflammatory response of macrophages stimulates CTR1-mediated copper uptake.
We then investigated the effect of proinflammatory agents
on another copper transporter, ATP7A, a copper-transporting
P-type ATPase responsible for delivering copper from the cytoplasm into secretory compartments. Immunoblot analysis
demonstrated that both IFN-␥ and LPS treatments increased
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the expression of ATP7A protein in RAW264.7 cells (Fig. 3, A
and B). A closely related copper transporter to ATP7A, known
as ATP7B, was not expressed in these cells (data not shown).
Taken together, these results suggest that the stimulation of
macrophages by LPS or IFN-␥ promotes copper uptake and
increases expression of CTR1 and ATP7A proteins.
IFN-␥ and LPS Stimulate Copper-dependent ATP7A Trafficking to Post-Golgi Vesicles That Overlap with the Phagosome—
Previous studies have demonstrated that elevated intracellular
copper levels stimulate the trafficking of the ATP7A protein from the trans-Golgi network to post-Golgi vesicles in a
variety of cell types (26 –29). Given that IFN-␥ or LPS stimulated copper uptake and increased cellular copper levels, we
surmised that these proinflammatory agents might also stimulate ATP7A trafficking. Using immunofluorescence microscopy, the ATP7A protein was identified in the perinuclear
region of untreated RAW264.7 macrophages, consistent with
its location in the trans-Golgi network (Fig. 4, top panels). As
expected, the addition of copper to the culture medium stimulated the trafficking of ATP7A to post-Golgi vesicles (Fig. 4,
second from top panels). Interestingly, when RAW264.7 cells
were exposed to IFN-␥ or LPS without copper supplementation, the ATP7A protein was also distributed to post-Golgi vesicles, although these punctae were not as clearly associated with
the cell periphery as in the case of copper treatment (Fig. 4,
third and fourth from top panels). The location of the Golgi
matrix marker protein, GM130, was not altered by IFN-␥ or
LPS, suggesting that the shift in ATP7A distribution was not the
result of general Golgi disruption (Fig. 4). Because the trafficking of ATP7A is known to be responsive to copper, we examined whether these effects of IFN-␥ could be inhibited using
the membrane-permeable copper chelator tetrathiomolybdate
VOLUME 284 • NUMBER 49 • DECEMBER 4, 2009
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phagosomes in IFN-␥-treated cells
(Fig. 7B). In separate experiments,
phagosomal membranes were purified from IFN-␥-treated RAW264.7
cells by subcellular fractionation
of membranes containing the internalized latex beads. Immunoblot analysis of this fraction demonstrated a marked enrichment of
the phagolysosomal marker LAMP-1
relative to total cell lysates, as well
as abundant levels of ATP7A protein (Fig. 7C). The phagosomal
fraction lacked the Golgi marker
protein, GM130, indicating that the
detection of ATP7A in these fractions was not an artifact of Golgi
contamination (Fig. 7C). Further
studies investigated whether ATP7A
partially colocalized with a constitutively active mutant of Rab7, a
GTPase involved in late endosome
fusion and required for lysosomal
biogenesis (30 –32). The constitutively active mutant Rab7-Q67L is
useful for co-localization studies
because it results in enlarged lysosomal structures (30). RAW264.7 cells
FIGURE 7. IFN-␥ stimulates partial trafficking of the ATP7A protein to the phagosomal compartment in were transiently transfected with
RAW264.7 macrophages. A, partial co-localization of ATP7A with phagosomal membranes. RAW264.7 macrophages were stimulated overnight with IFN-␥ and allowed to phagocytose latex beads to allow identification green fluorescent protein-tagged
of the phagosomal compartments (Bright field). B, ATP7A was detected by immunofluorescence microscopy in Rab7-Q67L and then exposed for
the same cells as in A. C, co-fractionation of ATP7A with the phagosomal membrane marker Lamp-1. IFN-␥- 24 h to basal medium or medium
stimulated RAW264.7 cells were allowed to phagocytose latex beads, and the phagosomal compartment was
isolated via subcellular fractionation. The bead fraction and total protein fraction were subjected to SDS-PAGE. containing 25 ng/ml IFN-␥. As
Immunoblot analysis revealed abundant ATP7A in Lamp-1-positive bead fraction, which lacked the Golgi shown in Fig. 7, in untreated cells
marker protein GM130. Note that Lamp-1 was poorly detected in total lysates. D, partial co-localization of
there was little overlap between the
ATP7A with Rab7-Q67L in IFN-␥-stimulated RAW264.7 cells. Cells were transiently transfected with green
fluorescent protein-tagged Rab7-Q67L plasmid and then exposed for 24 h to basal medium or medium con- perinuclear location of ATP7A and
taining 25 ng/ml IFN-␥. Cells were fixed, permeabilized, and probed with antibodies against ATP7A followed by Rab7-Q67L-containing compartanti-rabbit antibodies conjugated to Alexa-594.
ments (Fig. 7D). However, in cells
stimulated with IFN-␥, the ATP7A
(TTM). The treatment of RAW264.7 cells with TTM blocked protein was found to partially overlap with Rab7-Q67LIFN-␥-stimulated trafficking of ATP7A, consistent with a role containing compartments (Fig. 7D). Taken together, these
for copper in this trafficking process (Fig. 5A). Importantly, studies suggest that IFN-␥ activation of macrophages is assoWestern blot analysis of these same cells demonstrated that the ciated with partial redistribution of ATP7A to the phagolyincreased expression of ATP7A in response to either IFN-␥ or sosomal compartment.
ATP7A-dependent Copper Transport Is Required for BacteriLPS was not blocked by TTM (Fig. 5B). This finding indicated
that the inhibition of trafficking by TTM was not due to sup- cidal Activity of RAW264.7 Macrophages—The above findings
pression of ATP7A expression. In support of this conclusion, highlight the possibility that ATP7A-dependent copper
ATP7A trafficking was apparent within 3 h of IFN-␥ treatment transport into the phagosome might be important for mac(Fig. 6A), whereas the increases in ATP7A protein expression rophage microbiocidal activity. To test this hypothesis, we
investigated the effect of RNAi-mediated depletion of ATP7A
required a longer time period (Fig. 6B).
We then examined whether IFN-␥ might trigger the traffick- on bacterial killing in RAW264.7 cells. Stable transfection of
ing of ATP7A to the phagosomal compartment. The phagocy- a 29-nucleotide short hairpin RNAi plasmid against ATP7A
tosis of latex beads was used to identify phagosomes in IFN-␥- resulted in robust silencing of ATP7A gene expression (ATP7A
stimulated RAW264.7 cells (Fig. 7A, Bright field), and ATP7A RNAi cells), relative to control cells transfected with an irrelewas then detected in the same cells using immunofluorescence vant RNAi against green fluorescent protein (Fig. 8A). We then
microscopy (Fig. 7B). There was clear labeling of ATP7A out- confirmed that ATP7A-dependent copper transport was suplining the periphery of compartments that also contained the pressed in the ATP7A RNAi cells by testing the activity of copperinternalized beads, suggesting the presence of ATP7A within dependent enzyme, ceruloplasmin, a ferroxidase whose expres-
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exogenous copper, indicating that
the reduced bacterial killing was
attributable to a copper transport
defect rather than an unrelated
defect in the ATP7A-depleted cells
(Fig. 8D). These findings support
the hypothesis that ATP7A-dependent copper transport into the
phagosome is important for the bactericidal activity of macrophages.
We further explored the role of
copper homeostasis in bactericidal killing by testing whether the
ability of E. coli to export copper
might influence its susceptibility
to killing by RAW264.7 macrophages. The ⌬copA mutant strain
of E. coli is hypersensitive to elevated copper concentrations due to
the role of the CopA protein in the
extrusion of copper from the cytoplasm (33). The CopA protein is a
copper-transporting P-type ATPase
belonging to the same subfamily as
the ATP7A protein. The ⌬copA
mutant was markedly more susceptible to killing by RAW264.7 macrophages compared with its parental
wild type E. coli strain (Fig. 9A). SigFIGURE 8. E. coli survival is dependent on ATP7A expression in RAW264.7 macrophages. A, immunoblot nificantly, the susceptibility of the
analysis of ATP7A protein in RAW264.7 cells stably transfected with either ATP7A RNAi or control RNAi. B, Western blot analysis of ceruloplasmin protein in concentrated conditioned medium collected from ATP7A RNAi ⌬copA strain was dependent on
and control RNAi cells treated for 24 h in the presence or absence of 25 ng/ml IFN-␥. Note that ceruloplasmin ATP7A protein in the macrophage
basal expression or induction by IFN-␥ is not impaired by ATP7A depletion. C, ceruloplasmin activity was host because its survival was inassayed from concentrated conditioned medium from control RNAi or ATP7A RNAi macrophages treated for
24 h in the presence or absence of 20 M CuCl2. Values were normalized against total protein content of each creased in ATP7A RNAi cells relsample (mean ⫾ S.D.; n ⫽ 3; two-way analysis of variance). Note the suppression of ceruloplasmin activity in ative to control cells (Fig. 9B). ColATP7A-depleted cells and the rescue by the addition of copper. D, survival of wild type E. coli in control RNAilectively, these data suggest that
or ATP7A RNAi-transfected RAW264.7 cells pretreated overnight with 25 ng/ml IFN-␥ in the presence or
absence of 20 M CuCl2. Note that bacterial survival was significantly increased in ATP7A-depleted cells com- bacterial CopA and mammalian
pared with control cells and that copper pretreatment of ATP7A-depleted cells restored bactericidal activity to ATP7A are unique determinants
control levels (mean ⫾ S.D.; n ⫽ 3; two-way analysis of variance).
of macrophage-dependent bacterial
killing and identify an unexpected
sion is stimulated by IFN-␥. As expected, ceruloplasmin protein role for copper in host-pathogen interactions.
expression was stimulated by IFN-␥ in both ATP7A RNAi and
control cells (Fig. 8B). Because ceruloplasmin activity requires DISCUSSION
copper transport into secretory compartments, it can serve as a
Copper has long been recognized as a biocidal agent. Its
biomarker of ATP7A function. As shown in Fig. 8C, ceruloplas- modern day use in algaecides, fungicides, antimicrobial surmin activity was markedly reduced in the ATP7A RNAi cells faces, and medical devices can be traced back to its early use in
treated with IFN-␥, suggesting that the ATP7A-dependent the treatment of wounds by ancient Egyptian and Roman civicopper delivery to ceruloplasmin was reduced in these cells. lizations (34). In this study, we identify for the first time that
Control experiments confirmed this by showing that cerulo- specific changes in macrophage copper homeostasis mediate
plasmin activity could be restored after the addition of excess bacterial killing. Macrophage activation by proinflammatory
exogenous copper to ATP7A RNAi cells to bypass ATP7A-me- agents triggered increased copper uptake activity and a striking
copper-dependent relocalization of the ATP7A protein to a
diated copper transport (Fig. 8C).
Having confirmed a reduction in ATP7A-mediated copper vesicular distribution, which partially overlapped with the phagotransport activity in the ATP7A RNAi cells, we examined this somal compartment. In support of this trafficking event, a
effect on bacterial killing. E. coli killing experiments demon- recent analysis of the macrophage phagosomal proteome idenstrated a higher bacterial survival in ATP7A RNAi cells relative tified ATP7A in this compartment (35). Significantly, macroto control cells (Fig. 8D). This defect in bacterial killing was phage-mediated bacterial killing was dependent on the expresbypassed by pretreatment of ATP7A RNAi cells with excess sion of the ATP7A copper transporter, as evidenced by the
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FIGURE 9. The bacterial copper exporter, CopA, is a determinant of E. coli
survival in RAW264.7 macrophages. A, the survival of wild type (Wt) and
⌬copA deletion mutant E. coli in IFN-␥ stimulated RAW264.7 macrophages.
The percentage survival data is shown for 1 and 2 h kill times (postuptake)
(mean ⫾ S.D.; n ⫽ 3). B, the killing of ⌬copA mutant E. coli is attenuated in
ATP7A-depleted RAW264.7 macrophages. ATP7A RNAi- and control RNAitransfected cells were stimulated overnight with IFN-␥ (mean ⫾ S.D.; n ⫽ 3).

attenuated bactericidal activity when ATP7A was silenced.
These findings suggest that copper transport into the phagosome via the ATP7A protein is a novel determinant of bacterial killing by macrophages. Consistent with this hypothesis,
recent studies using x-ray microprobe analysis have demonstrated that copper levels within the phagosome increase
10-fold to ⬃180 M in IFN-␥-stimulated macrophages exposed
to M. avium (18).
How might this enrichment of copper promote bacterial killing by macrophages? One possibility is the copper-catalyzed
production of the hydroxyl radical from hydrogen peroxide via
Fenton-like chemistry. Although hydrogen peroxide is generated spontaneously from superoxide created by the respiratory
burst, it is only lethal to bacteria at supraphysiological millimolar concentrations (36). However, physiological concentrations
of hydrogen peroxide and cuprous ions are lethal to E. coli (22).
Iron-mediated hydroxyl radical production is also toxic to bacteria in vitro (37); however, a role for iron in macrophage bactericidal activity is unlikely because iron accumulation in the
phagosome is decreased in IFN-␥-stimulated macrophages,
and iron treatment of macrophages reduces bactericidal activDECEMBER 4, 2009 • VOLUME 284 • NUMBER 49

ity (38). These findings, together with those of our study, suggest that a lethal combination of copper and hydrogen peroxide
may be the underlying mechanism by which ATP7A-dependent copper transport into the phagosome promotes bacterial
killing.
An important finding of our study was that the copper-sensitive ⌬copA mutant of E. coli was more susceptible to macrophage-mediated killing than the wild type strain. Because the
CopA protein functions in the extrusion of cytoplasmic copper
across the plasma membrane (33), these findings suggest that
copper export is a bacterial defense mechanism against macrophage-mediated killing. Consistent with this hypothesis, the
susceptibility of the ⌬copA mutant to killing was ameliorated by
depletion of ATP7A in RAW264.7 macrophage cells. These
findings suggest that copper transport by both host and pathogen is a unique and mutually opposing tactic in the struggle for
supremacy; i.e. ATP7A-mediated copper transport into the
phagosome appears to be countered by copper extrusion by the
bacterium. Indeed, there is evidence to suggest that copper
export might be a defense strategy that is generally applicable to
other pathogenic bacteria. For example, the virulence of
Pseudomonas aeruginosa in mice is severely decreased (20-fold)
by mutations in the copper exporter, CueA (39). Additionally,
the expression of several metal ion exporters, including two
putative copper efflux transporters, CopA1 and CopA2, are
induced in Legionella pneumophila upon phagocytosis by macrophages (40). Moreover, plasmids that increase the virulence
of Klebsiella pneumoniae and Shigella sonnei harbor putative
copper resistance genes (41, 42).
In light of our findings, it is notable that bacterial infections,
especially those of the respiratory tract, are commonly reported
in infants with Menkes disease, in whom genetic mutations in
the ATP7A gene give rise to copper deficiency (43– 46). However, it is uncertain whether this susceptibility to infections
arises from defects in ATP7A-dependent activities of macrophages or impairment of other copper-requiring processes.
Deciphering the role of ATP7A in innate immunity in vivo will
require myeloid-specific ATP7A knock-out mice, which we are
currently generating.
It is notable that changes in the serum concentration of
micronutrients following infection are characteristic of the
acute phase inflammatory response. Serum levels of iron,
zinc, selenium, retinol, riboflavin, and pyridoxine are all
reported to decrease following inflammatory insult (47). The
proposed physiological rationale for these changes is nutrient deprivation to limit proliferation of the invading microbe
(47). A well documented example is the contest between host
and pathogen over limiting iron stores, which plays a critical
role in determining the outcome of infection (48). In contrast, however, systemic copper concentrations are widely
reported to increase in response to acute and chronic inflammation (49 – 65). Although the secreted copper-containing
protein, ceruloplasmin, is partially responsible for this rise in
serum copper (66), the non-protein-bound fraction of copper
in the serum is also increased during inflammation (49). Moreover, radiotracer studies with 64Cu have demonstrated that
copper accumulates at sites of inflammation (67) and within the
exudates of wounds and burns where there exists an abundance
JOURNAL OF BIOLOGICAL CHEMISTRY
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of macrophages (68, 69). Our findings underscore the possibility that these changes in systemic copper concentrations may
provide localized reserves of copper for macrophage-mediated
bactericidal activity.
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